AbbVie Inc (NYSE:ABBV)

Wednesday’s trading has closed, but ABBV is being traded in the after-hours session. After-Hours quote »
57.10
Delayed Data
As of 4:01pm ET
 -1.44 / -2.46%
Today’s Change
45.50
Today|||52-Week Range
70.76
-12.74%
Year-to-Date
Infinity Pharmaceuticals Exercises Duvelisib Royalty Option - Analyst Blog
4:03pm / Zacks.com
Pharmacyclics chief to receive $3.6bn from takeover
Mar 23 / FT.com
Why Coherus BioSciences Inc. Shares Burst Today
1:06pm / MotleyFool.com
This Market Could Grow 6250% in 10 Years
Mar 23 / MotleyFool.com
The Zacks Analyst Blog Highlights: Google, Johnson & Johnson, AbbVie, Yahoo and Micro...
Mar 31 / Zacks.com
Better Dividend Stock: AbbVie or Gilead Sciences, Inc.?
Mar 23 / MotleyFool.com
The Single Worst Practice of the Drug Industry
Mar 31 / MotleyFool.com
3 Things You Need to Know About Achillion Pharmaceuticals Inc.
Mar 22 / MotleyFool.com
Biogen/AbbVie's MS Drug Zinbryta Under Review in the EU - Analyst Blog
Mar 30 / Zacks.com
Confessions of a Value Investor Stuck in a High-Growth Industry
Mar 22 / MotleyFool.com
Healthcare Merger Monday: These 3 Stocks Could Be Healthcare's Next Buyout Targets
Mar 30 / MotleyFool.com
Dividend Stocks: 2 to Avoid, 1 to Buy
Mar 21 / MotleyFool.com
Healthcare sector leads feverish M&A activity
Mar 30 / FT.com
Drug Spending Is Soaring: 3 Takeaways You Can't Miss
Mar 21 / MotleyFool.com
Biotech Merger Monday Doesn't Squash Biotech Bubble Debate
Mar 30 / TheStreet.com
Celgene's Data on Crohn's Disease Candidate Published - Analyst Blog
Mar 19 / Zacks.com
Is Gilead Sciences Inc. About to Crater Before Our Very Eyes?
Mar 29 / MotleyFool.com
Aldeyra Initiates Phase II Sjogren-Larsson Syndrome Study - Analyst Blog
Mar 19 / Zacks.com
Biotech, Chips Stand Their Ground; Be Careful What You Wish For: Jim Cramer's Best Bl...
Mar 28 / TheStreet.com
Going the extra mile to win a B#21bn deal
Mar 06 / FT.com
7 Top Science Fiction Projects That Could Make or Break Google, Amazon or Facebook
Mar 27 / TheStreet.com
AbbVie wins three-way fight over Pharmacyclics
Mar 05 / FT.com
Biotech, Chips Stand Their Ground
Mar 27 / TheStreet.com
AbbVie joins the pharma chain reaction
Mar 05 / FT.com
US Stock Futures Edge Lower Ahead Of GDP, Consumer Sentiment Data
Mar 27 / Benzinga
Vertex climbs on drug approval hopes
Mar 05 / FT.com
Biotechs Need to Rest
Mar 27 / TheStreet.com
Centerview builds record on pharma deals
Mar 05 / FT.com
Drugs companies unite to mine genetic data
Mar 25 / FT.com
Abbvie/Pharmacyclics: pay to play
Mar 05 / FT.com
4 Top-Ranked Health Care ETFs for a Healthy Portfolio - ETF News And Commentary
Mar 25 / Zacks.com
Q&A - why Abbvie had to strike $21bn Pharmacyclics deal
Mar 05 / FT.com
Biotech Stock Roundup: Biogen Soars on Alzheimer's Data, Gilead HCV Drugs Label Updat...
Mar 25 / Zacks.com
Stocks: 5 things to know before the open
Mar 05 / CNNMoney.com

To view my watchlist

Not a member yet?

Sign up now for a free account